Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously renew...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prenatal diagnosis, associated findings and postnatal outcome of fetuses with truncus arteriosus communis (TAC).

Archives of gynecology and obstetrics·2021
Same author

Prenatal diagnosis, associated findings and postnatal outcome of fetuses with truncus arteriosus communis (TAC).

Archives of gynecology and obstetrics·2021
Same author

Cav2.3 R-type calcium channels: from its discovery to pathogenic de novo CACNA1E variants: a historical perspective.

Pflugers Archiv : European journal of physiology·2020
Same author

Catheter ablation in ASymptomatic PEDiatric patients with ventricular preexcitation: results from the multicenter "CASPED" study.

Clinical research in cardiology : official journal of the German Cardiac Society·2018
Same author

In vitro and in vivo phosphorylation of the Ca<sub>v</sub>2.3 voltage-gated R-type calcium channel.

Channels (Austin, Tex.)·2018
Same author

[Hypothermia-induced ECG changes: characteristic, but not specific].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2017
Same journal

Mechanistic factors of cardiovascular diseases.

Minerva cardioangiologica·2020
Same journal

Robotic-assisted coronary artery bypass grafting: current knowledge and future perspectives.

Minerva cardioangiologica·2020
Same journal

Features of degenerative mitral valve prolapse in the North East of China: repair characteristics, and short-term follow-up results.

Minerva cardioangiologica·2020
Same journal

Myocardial revascularization in chronic coronary syndromes: does viability matter?

Minerva cardioangiologica·2020
Same journal

Extracorporeal membrane oxygenation for COVID-19: effective weapon or futile effort?

Minerva cardioangiologica·2020
Same journal

Heart and endurance sports: excesses are often unhealthy.

Minerva cardioangiologica·2020
See all related articles

Related Experiment Video

Updated: Jul 4, 2026

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions
12:48

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Published on: January 7, 2019

Stem cells in pediatric heart failure.

F Pillekamp1, M Khalil, M Emmel

  • 1Department of Pediatric Cardiology, University of Cologne, Cologne, Germany.

Minerva Cardioangiologica
|May 30, 2008
PubMed
Summary
This summary is machine-generated.

Pediatric heart failure may benefit from regenerative therapy using stem cells. Induced pluripotent stem cells offer a promising, ethically sound alternative for developing functional cardiomyocytes in children.

More Related Videos

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells
09:05

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

Published on: August 9, 2017

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Related Experiment Videos

Last Updated: Jul 4, 2026

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions
12:48

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Published on: January 7, 2019

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells
09:05

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

Published on: August 9, 2017

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Area of Science:

  • Regenerative Medicine
  • Cardiology
  • Stem Cell Biology

Background:

  • Pediatric heart failure presents unique challenges with limited therapeutic options for conditions like dilated cardiomyopathy.
  • Current treatments for pediatric heart failure have a high mortality rate, with many children requiring transplants or succumbing within two years.

Purpose of the Study:

  • To review potential stem cell sources for regenerative therapy in pediatric heart failure.
  • To identify pediatric heart conditions most likely to benefit from cell-based treatments and suitable cell types.

Main Methods:

  • Review of existing literature on stem cell therapies for heart failure.
  • Analysis of stem cell differentiation capabilities and ethical considerations.
  • Comparison of adult and pediatric heart failure pathophysiology.

Main Results:

  • Embryonic stem cells can differentiate into cardiomyocytes but pose ethical and immunological concerns.
  • Adult stem cells have shown limited therapeutic benefit in adults.
  • Induced pluripotent stem cells (iPSCs) derived from somatic cells offer a potential solution, bypassing ethical and immunological issues.

Conclusions:

  • Stem cell-based regenerative therapy holds promise for pediatric heart failure.
  • Induced pluripotent stem cells represent a viable and ethically preferable option for generating functional cardiomyocytes.
  • Further research is crucial to translate these findings into clinical applications for pediatric patients, considering age-specific pathophysiology.